Evaluation of CD4+ T cell function in vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization

Journal of Infectious Diseases

Volumn 182, Issue 2, 2000, Pages 435-441

  Fogelman, Ilana ^a   Davey, Victoria ^c   Ochs, Hans D ^d   Elashoff, Michael ^b   Feinberg, Mark B ^e   Mican, Jo Ann ^c   Siegel, Jay P ^a   Sneller, Michael ^c   Lane, H Clifford ^c  

^a Office of Blood Review and Research (OBRR)   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BACTERIOPHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; LEUKOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIBODY FORMATION; B-LYMPHOCYTES; BACTERIOPHAGE PHI X 174; FEMALE; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC MEMORY; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION;

EID: 0033845214     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315739     Document Type: Article

References (24)

1. Changing patterns of mortality across Europe in patients infected with HIV-1
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. + T cell homeostasis and function in advanced HIV disease
4. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities: Swiss HIV Cohort Study
5. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
6. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
7. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
8. + repertoire during antiviral therapy
9. Cognate interactions between helper T cells and B cells
10. Immuunologic responses to bacteriophage phiX174 in immunodeficiency diseases
11. The recognition and classification Of immunodeficiency diseases with bacteriophage phiChi 174
12. Antibody responses to bacteriophage phiX174 in patients with adenosine deaminase deficiency
13. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome
14. Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency
15. Defective humoral immunity in pediatric acquired immune deficiency syndrome
16. Abnormal antibody responses in patients with persistent generalized lymphadenopathy
17. Human antibody responses to bacteriophage phiX174: Sequential induction of IgM and IgG subclass antibody
18. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection
19. Correlations between immunologic indices and thymic mass in HIV infected patients following 48 weeks of therapy with zidovudine, lamivudine and ritonavir (ZLR)
20. Changes in thymic function with age and during the treatment of HIV infection
21. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy
22. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study
23. Functional B cell abnormalities in HIV type 1 infection: Role of CD40L and CD70
24. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM